RecruitingNCT00830557
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
Studying Functioning neuroendocrine tumor of pancreas
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Mayo Clinic
- Principal Investigator
- Shounak Majumder, MDMayo Clinic
- Intervention
- medical chart review(other)
- Enrollment
- 20000 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2000 – 2027
Study locations (3)
- Mayo Clinic Hospital in Arizona, Phoenix, Arizona, United States
- Mayo Clinic in Florida, Jacksonville, Florida, United States
- Mayo Clinic in Rochester, Rochester, Minnesota, United States
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00830557 on ClinicalTrials.govOther trials for Functioning neuroendocrine tumor of pancreas
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE3NCT04919226Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSEITM Solucin GmbH
- ACTIVE NOT RECRUITINGPHASE3NCT03375320Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid TumorsNational Cancer Institute (NCI)
See all trials for Functioning neuroendocrine tumor of pancreas →